NL8320264A - Perfluorkoolstof-emulsies, hun bereiding en hun toepassing in de therapie. - Google Patents

Perfluorkoolstof-emulsies, hun bereiding en hun toepassing in de therapie. Download PDF

Info

Publication number
NL8320264A
NL8320264A NL8320264A NL8320264A NL8320264A NL 8320264 A NL8320264 A NL 8320264A NL 8320264 A NL8320264 A NL 8320264A NL 8320264 A NL8320264 A NL 8320264A NL 8320264 A NL8320264 A NL 8320264A
Authority
NL
Netherlands
Prior art keywords
dispersion
oxygen
pfv
aqueous pharmaceutical
radiation
Prior art date
Application number
NL8320264A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sun Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL8320264(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sun Tech Inc filed Critical Sun Tech Inc
Publication of NL8320264A publication Critical patent/NL8320264A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8320264A 1982-08-17 1983-08-10 Perfluorkoolstof-emulsies, hun bereiding en hun toepassing in de therapie. NL8320264A (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US40858982A 1982-08-17 1982-08-17
US40858982 1982-08-17
US51715083A 1983-07-25 1983-07-25
US51715083 1983-07-25
US8301237 1983-08-10
PCT/US1983/001237 WO1984000686A1 (en) 1982-08-17 1983-08-10 Perfluorocarbon emulsions and their preparation and use in therapy

Publications (1)

Publication Number Publication Date
NL8320264A true NL8320264A (nl) 1984-07-02

Family

ID=27020315

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8320264A NL8320264A (nl) 1982-08-17 1983-08-10 Perfluorkoolstof-emulsies, hun bereiding en hun toepassing in de therapie.

Country Status (19)

Country Link
EP (1) EP0105584B1 (es)
JP (1) JPS59501665A (es)
KR (1) KR890002204B1 (es)
AU (1) AU559559B2 (es)
CA (1) CA1225027A (es)
CH (1) CH665952A5 (es)
DE (2) DE3378954D1 (es)
ES (1) ES524972A0 (es)
FI (1) FI841513A (es)
GB (1) GB2134787A (es)
GR (1) GR79383B (es)
IE (1) IE55618B1 (es)
IL (1) IL69505A (es)
NL (1) NL8320264A (es)
NO (1) NO841519L (es)
PH (2) PH25492A (es)
PT (1) PT77204B (es)
SE (1) SE8402098L (es)
WO (1) WO1984000686A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59130813A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JPS59130812A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
CA1257828A (en) * 1984-04-16 1989-07-25 William Mccormick Perfluoro compound dispersions containing reduced amounts of surfactant and process of preparation
US4815446A (en) * 1985-05-09 1989-03-28 Alpha Therapeutic Corporation Process for treating metastasis of cancerous tumors
US4781676A (en) * 1987-02-20 1988-11-01 Air Products And Chemicals, Inc. Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
US4956390A (en) * 1987-08-25 1990-09-11 Air Products And Chemicals, Inc. Gas transport employing perfluorobutyldecalin
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
JP2935519B2 (ja) * 1989-08-28 1999-08-16 シーキンス，ケイ・マイケル 超音波および／またはペルフルオロカーボン液での対流を介する肺癌高熱治療
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
FR2679150A1 (fr) * 1991-07-17 1993-01-22 Atta Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
AU3924193A (en) * 1992-03-19 1993-10-21 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
US5643601A (en) * 1992-06-26 1997-07-01 Lancaster Group Ag Phospholipid-and fluorocarbon-containing cosmetic
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
EP1100366B1 (en) * 1998-07-09 2009-04-15 Curelight Medical Ltd Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea
US20040122492A1 (en) 1999-07-07 2004-06-24 Yoram Harth Phototherapeutic treatment of skin conditions
GB0200721D0 (en) * 2002-01-14 2002-02-27 Univ Bristol Toxicity test
EP2587917A4 (en) * 2010-07-01 2015-05-06 Mtm Res Llc THERAPIES USING ANTIFIBROBLASTIC FLUOROCHEMICAL EMULSIONS

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828085A (en) * 1970-07-09 1974-08-06 Allied Chem Novel amidoamine oxides
US3823091A (en) * 1971-05-19 1974-07-09 Green Cross Corp Stable emulsion of fluorocarbon particles
US4041086A (en) * 1972-02-07 1977-08-09 Sun Ventures, Inc. Process of manufacture of flourinated alkyladamantanes
US3911138B1 (en) * 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
JPS5331209B2 (es) * 1973-10-05 1978-09-01
DE2524363A1 (de) * 1975-06-02 1976-12-16 Boehringer Sohn Ingelheim Neue pharmazeutische mittel
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
JPS5331209A (en) * 1976-09-03 1978-03-24 Hitachi Ltd Small compressor cylinder for refrigerating machine and production of same
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
JPS6033367B2 (ja) * 1978-11-24 1985-08-02 株式会社ミドリ十字 酸素運搬輸液
US4282232A (en) * 1979-04-26 1981-08-04 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
WO1981000002A1 (en) * 1979-06-25 1981-01-08 Suntech Use of perfluorocarbon as burn treatment
CA1181011A (en) * 1980-05-27 1985-01-15 Robert P. Geyer Perfluorinated n,n-dimethyl cyclohexylmethylamine and emulsions containing the same
GR78151B (es) * 1982-04-05 1984-09-26 Alcon Lab Inc

Also Published As

Publication number Publication date
DE3390172T1 (de) 1984-11-29
IE831925L (en) 1984-02-17
NO841519L (no) 1984-04-16
DE3378954D1 (en) 1989-02-23
SE8402098D0 (sv) 1984-04-16
PT77204B (en) 1986-02-04
ES8502405A1 (es) 1985-01-01
WO1984000686A1 (en) 1984-03-01
CA1225027A (en) 1987-08-04
PT77204A (en) 1983-09-01
AU1941383A (en) 1984-03-07
IE55618B1 (en) 1990-11-21
CH665952A5 (de) 1988-06-30
JPS59501665A (ja) 1984-10-04
EP0105584A1 (en) 1984-04-18
IL69505A0 (en) 1983-11-30
EP0105584B1 (en) 1989-01-18
AU559559B2 (en) 1987-03-12
GB2134787A (en) 1984-08-22
FI841513A0 (fi) 1984-04-16
IL69505A (en) 1990-03-19
PH25492A (en) 1991-07-24
FI841513A (fi) 1984-04-16
KR840005660A (ko) 1984-11-15
GR79383B (es) 1984-10-22
KR890002204B1 (ko) 1989-06-23
PH25027A (en) 1991-01-28
SE8402098L (sv) 1984-04-16
ES524972A0 (es) 1985-01-01

Similar Documents

Publication Publication Date Title
NL8320264A (nl) Perfluorkoolstof-emulsies, hun bereiding en hun toepassing in de therapie.
US5403575A (en) Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
US5077036A (en) Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
US4927623A (en) Dissolution of gas in a fluorocarbon liquid
US5344393A (en) Use of synthetic oxygen carriers to facilitate oxygen delivery
USRE38081E1 (en) Method of hemodilution facilitated by monitoring oxygenation status
PL169372B1 (en) Method of obtaining a pharmaceutical composition containing novel derivative of taxames group
EP0480925B1 (en) Fluorocarbon emulsions having saturated phospholipid emulsifiers
US4889525A (en) Sensitization of hypoxic tumor cells and control of growth thereof
US4742050A (en) Sensitization of hypoxic tumor cells and control of growth thereof
Clark et al. Perfluorocarbons: future clinical possibilities
JPH0372423A (ja) パーフルオロカーボン化合物含有乳化製剤
Guichard The use of fluorocarbon emulsions in cancer radiotherapy
CA1335714C (en) Fluorocarbon emulsions having saturated phospholipid emulsifiers
Lowe Perfluorochemical blood substitutes: circulatory and biomedical applications
PH26149A (en) Perfluorocarbon emulsions and their preparation
CA2315877C (en) Facilitated oxygen delivery in conjunction with hemodilution
MXPA97009697A (es) Hemodulacion facilitada por el monitoreo de la condicion de oxigenacion
JPH02184625A (ja) 抗癌活性を有する薬剤組成物および抗癌活性増強剤